Effects of Protein-rich Supplementation and Nandrolone on Bone Tissue After a Hip Fracture
Affiliations
Background & Aims: Osteoporosis is a major health problem worldwide. Low weight is a major risk factor for low bone mass and fractures. The aim of this study was to investigate the effects on bone tissue of protein-rich supplementation alone or in combination with nandrolone decanoate in lean elderly women after a hip fracture.
Methods: Sixty elderly women with BMI <24 kg/m(2) admitted to hospital due to a femoral neck fracture were randomised to a control group, to receive a protein-rich formula or to receive the same formula with an addition of nandrolone decanoate for 6 months. All patients received additional calcium and vitamin D. The effects after 6 and 12 months were measured by means of bone mineral density (BMD) using dual-energy X-ray absorptiometry (DXA), and with biochemical bone markers. Osteocalcin and C-terminal telopeptide of collagen-1 (CTX) were used to estimate bone formation and bone resorption, respectively.
Results: The analyses showed an increase in total body BMD at 6 and 12 months in patients who received protein-rich supplementation. Nandrolone decanoate did not appear to have any additional effect on BMD. Osteocalcin increased in all groups while no significant changes were found for CTX.
Conclusion: The overall results of the study indicated that protein-rich supplementation given to lean elderly female hip fracture patients increased the total body BMD.
Je M, Kang K, Yoo J, Kim Y Nutrients. 2023; 15(20).
PMID: 37892460 PMC: 10610213. DOI: 10.3390/nu15204386.
Post-surgery interventions for hip fracture: a systematic review of randomized controlled trials.
Phang J, Lim Z, Yee W, Tan C, Kwan Y, Low L BMC Musculoskelet Disord. 2023; 24(1):417.
PMID: 37231406 PMC: 10210378. DOI: 10.1186/s12891-023-06512-9.
Chen L, Liu Y, Chen S, Su H Nutrients. 2023; 15(3).
PMID: 36771312 PMC: 9919494. DOI: 10.3390/nu15030605.
Pinto D, Alshahrani M, Chapurlat R, Chevalley T, Dennison E, Camargos B Osteoporos Int. 2022; 33(3):527-540.
PMID: 35048200 DOI: 10.1007/s00198-021-06240-7.
Anabolic Androgenic Steroids in Orthopaedic Surgery: Current Concepts and Clinical Applications.
Weber A, Gallo M, Bolia I, Cleary E, Schroeder T, Hatch 3rd G J Am Acad Orthop Surg Glob Res Rev. 2022; 6(1).
PMID: 34982051 PMC: 8735789. DOI: 10.5435/JAAOSGlobal-D-21-00156.